1. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P. 1987. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma: A randomized trial. Ann Intern Med 107:459–465.
2. Martin JK Jr., O’Connell MJ, Wieand HS, Fitzgibbons RJ Jr., Mailliard JA, Rubin J, Nagorney DM, Tschetter LK, Krook JE. 1990. Intra-arterial floxuridine vs. systemic fluorouracil for hepatic metastases from colorectal cancer: A randomized trial. Arch Surg 125:1022–1027.
3. Nobile MT, Vidili MG, Sertoli MR, Venturini M, Simoni G, Civalleri D, Bertoglio S, Percivale P, Torelli P, Spagliardi E, Rosso R. 1991. Intrahepatic Epidoxorubicin in metastatic and primary liver tumours: A phase II study. Anticancer Res 11:861–864.
4. Sterchi JM, Richards F, White DR, Muss HB, Cooper MR, Jackson DV, Spurr CL, Capizzi RL, Cruz J, Zekan PJ. 1989. Chemoinfusion of the hepatic artery for metastases to the liver. Surg Gynecol Obstet 168:291–295.
5. Wagman LD, Kemeny N, Leong L, Terz JJ, Hill LR, Beatty JD, Kokal WA, Riihimaki DU. 1990. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 8:1885–1893.